Status:
COMPLETED
Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT)
Lead Sponsor:
Duke University
Collaborating Sponsors:
Abbott Medical Devices
Conditions:
Cardiomyopathy
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether using an echocardiogram (a painless test where ultrasound is used to see your heart) while using mild electrical stimulation from your own CRT-D devic...
Eligibility Criteria
Inclusion
- LVEF \</= 35% as assessed by echocardiography.
- New York Heart Association Functional Class III or IV CHF despite contemporary medical therapy for CHF.
- QRS duration of \>/= 120 ms.
- Ability to provide written, informed consent.
- Age \> 18 years.
- Successful implant of a biventricular/ICD pacemaker device.
Exclusion
- Documented Chronic Atrial Fibrillation
- Life expectancy less that 6 months due to non-cardiac causes
- Inability to place a coronary sinus left ventricular pacing lead
- Pregnancy
- Scheduled cardiac surgery within the next 6 months
- Prosthetic Tricuspid Valve
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00737490
Start Date
June 1 2005
End Date
July 1 2011
Last Update
August 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Medical Center
Durham, North Carolina, United States, 27710